| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
TXT
|
Philipp Strauss
|
||||||
| GSE76207 |
Transcriptome Sequencing (RNAseq) enables utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development
|
64 |
|
Philipp Strauss | Jan 08, 2016 | |||
| GSE82122 |
Confirmation dataset of Transcriptome Sequencing (RNAseq) data utilizing Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development
|
24 |
|
Philipp Strauss | Nov 21, 2016 | |||
| GSE166239 |
Partial epithelial-to-mesenchymal transition (EMT) and T cell-mediated inflammation in hypertensive and diabetic nephropathy
|
18 |
|
Philipp Strauss | Dec 01, 2023 | |||
| GSE171955 |
AGAP2-AS1 as prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease
|
24 |
|
Philipp Strauss | Dec 29, 2021 | |||
| GSE210098 |
Glomerular transcriptomics predicts outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy
|
17 |
|
Philipp Strauss | May 01, 2024 | |||
| GSE207557 |
A multiomics disease progression signature of low-risk ccRCC
|
24 |
|
Philipp Strauss | Aug 10, 2022 |
